Molly L Tanenbaum1, Persis V Commissariat2. 1. Department of Pediatrics, Division of Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, USA. mollyt@stanford.edu. 2. Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, Boston, MA, USA.
Abstract
PURPOSE OF REVIEW: Diabetes technology (insulin pumps, continuous glucose monitoring, automated insulin delivery systems) has advanced significantly and provides benefits to the user. This article reviews the current barriers to diabetes device adoption and sustained use, and outlines the known and potential facilitators for increasing and sustaining device adoption. RECENT FINDINGS: Barriers to diabetes device adoption continue to exist at the system-, provider-, and individual-level. Known facilitators to promote sustained adoption include consistent insurance coverage, support for providers and clinics, structured education and support for technology users, and device user access to support as needed (e.g., through online resources). Systemic barriers to diabetes device adoption persist while growing evidence demonstrates the increasing benefits of newest devices and systems. There are ongoing efforts to develop evidence-based structured education programs to support device adoption and sustained use.
PURPOSE OF REVIEW: Diabetes technology (insulin pumps, continuous glucose monitoring, automated insulin delivery systems) has advanced significantly and provides benefits to the user. This article reviews the current barriers to diabetes device adoption and sustained use, and outlines the known and potential facilitators for increasing and sustaining device adoption. RECENT FINDINGS: Barriers to diabetes device adoption continue to exist at the system-, provider-, and individual-level. Known facilitators to promote sustained adoption include consistent insurance coverage, support for providers and clinics, structured education and support for technology users, and device user access to support as needed (e.g., through online resources). Systemic barriers to diabetes device adoption persist while growing evidence demonstrates the increasing benefits of newest devices and systems. There are ongoing efforts to develop evidence-based structured education programs to support device adoption and sustained use.
Authors: L Indelicato; V Mariano; S Galasso; F Boscari; E Cipponeri; C Negri; A Frigo; A Avogaro; E Bonora; M Trombetta; D Bruttomesso Journal: Diabet Med Date: 2017-02-20 Impact factor: 4.359
Authors: J Lawton; B Kimbell; D Rankin; N L Ashcroft; L Varghese; J M Allen; C K Boughton; F Campbell; T Randell; R E J Besser; N Trevelyan; R Hovorka Journal: Diabet Med Date: 2020-02-14 Impact factor: 4.359
Authors: Priya Prahalad; Osagie Ebekozien; G Todd Alonso; Mark Clements; Sarah Corathers; Daniel DeSalvo; Marisa Desimone; Joyce M Lee; Ilona Lorincz; Ryan McDonough; Shideh Majidi; Ori Odugbesan; Kathryn Obrynba; Nicole Rioles; Manmohan Kamboj; Nana-Hawa Yayah Jones; David M Maahs Journal: Clin Diabetes Date: 2021-07
Authors: Aneta Hásková; Lucie Radovnická; Lenka Petruželková; Christopher G Parkin; George Grunberger; Eva Horová; Vendula Navrátilová; Ondřej Kádě; Martin Matoulek; Martin Prázný; Jan Šoupal Journal: Diabetes Care Date: 2020-08-28 Impact factor: 19.112